The listed company Galmed plans to allocate 50% of its cash reserves to cryptocurrency
ChainCatcher news, according to PR Newswire, the US-listed biopharmaceutical company Galmed Pharmaceuticals Ltd. announced the implementation of a digital asset management strategy, with plans to allocate $10 million (approximately 50% of current cash reserves) for digital asset investments.
The company has established a cryptocurrency committee responsible for evaluating and overseeing cryptocurrency-related investment activities. This strategy will include digital asset portfolio rebalancing, participation in liquidity provision, staking yields, and risk hedging strategies.
To execute this plan, Galmed has signed a letter of intent with cryptocurrency asset management service provider Tectona (TASE: TECT), which will provide consulting and operational services.
ChainCatcher reminds readers to view blockchain rationally, enhance risk awareness, and be cautious of various virtual token issuances and speculations. All content on this site is solely market information or related party opinions, and does not constitute any form of investment advice. If you find sensitive information in the content, please click , and we will handle it promptly.







